The Children’s Tumor Foundation (CTF) is excited to announce that Nathalie Moll, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), will be providing the Opening Address at our annual Global NF Conference in Brussels this June. Ms. Moll has spent 20 years working for the biotech industry at EU and national level associations and corporations. In 2013, she was awarded the Technovisionaries Women Innovation Award organized by Women & Technologies(R) and was also named one of 15 leading women in biotech in Europe in 2017. The announcement of our Opening Speaker is a testament to the continued focus of CTF on international collaboration and open data sharing to End NF.
About the Global NF Conference
Hosted by CTF Europe, the 2024 NF Conference is organized by the Children’s Tumor Foundation and the European NF Group and will take place June 20-25, 2024 in Brussels, Belgium. The Global NF Conference is the most important annual gathering of the NF research and clinical communities, focused on drug development and improved outcomes for patients living with NF. It’s a global event attracting over 1,000 participants across various scientific disciplines and a critical forum for advancing basic, translational, and clinical research in NF. At the Global NF Conference, you’ll have the opportunity to engage with both seasoned experts and fresh faces in the NF field.
To learn more about the upcoming Global NF Conference, click here.
